Intermountain Medical Center Heart Institute News
Researchers found the risk of a patient having a secondary event or dying decreased in those who had a follow-up LDL test before a subsequent adverse outcome or before the end of their follow-up.
They were split into three different groups which received varied doses of testosterone administered either by injection or gel.
Loading...